(NASDAQ:IXHL), MELBOURNE, Australia and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for IHL-42X, the Company's oral fixed-dose combination product candidate for the treatment of obstructive sleep apnea […]

(NASDAQ:ABL),(NASDAQ:ABLLW), ORLANDO, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) — Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its participation in the following upcoming investor conferences. The Company will participate in the Sidoti Year-End Virtual Investor Conference, being held December 10-11, 2025. Chief Executive

SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Flowace.ai, an AI-powered productivity analytics platform that helps organizations improve workforce efficiency through intelligent, ethical insights, today announced the expansion of its AI-powered productivity analytics platform. The platform is built to help organizations understand how work happens, optimize performance, and strengthen workforce resilience against rising automation. Designed

LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) — The 2025 Beauty Innovation Awards today announced K-beauty brand Saranghae's Advanced Brightening Dark Spot Repair Serum has been selected as “Anti-Blemish Product of the Year.” The Beauty Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Beauty

(NYSE MKT:MCRP), DUBAI, United Arab Emirates, Dec. 03, 2025 (GLOBE NEWSWIRE) — Micropolis AI Robotics (“Micropolis” or the “Company”) (NYSE: MCRP), a leading UAE-based developer of autonomous mobile robots and AI-driven security solutions, announced today that it has signed a non-binding Letter of Intent (“LOI”) with QSS Robotics, a prominent Saudi Arabian technology company, to

Biotech veteran with over 25 years of business development, strategy and operational experience joins March Bio's management team HOUSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) — March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced the appointment of Gurpreet Ratra, Ph.D., as Chief Business Officer.

Rising demand for governed communication meets rapid go-to-market acceleration as LeapXpert joins AVANT's ecosystem, bringing The LeapXpert Communications Platform to partners serving regulated and high-trust industries LeapXpert, the leader in responsible business communication, today announced that it has partnered with AVANT, making The LeapXpert Communications Platform available through a global network of 4,000+ Trusted Advisors,

(NasdaqGM:STRO), – Initial clinical data expected mid-2026 – SOUTH SAN FRANCISCO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that the patients in the first cohort have been dosed in its Phase

BERKELEY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced the completion of Project UPWARDS which advances the development of a first-of-a-kind integrated waste management system for advanced reactors. Delivered on time and on budget with grant support

Improvesrankingto#36;retainspolepositioninModelValidationcategory Crisil Ltd, the global provider of advanced analytics and credit risk management solutions, has risen one place to #36 in the RiskTech100 2026 report published by Chartis Research this month. This is the third consecutiveyearCrisil has earned a Top 50 ranking, improving steadily from #49 in 2024 to #37 this year, and #36 in